dimanche 3 mars 2024

Alarming News for the Shingle Vaccine Recipients

Getting the recombinant zoster (shingles) vaccine (RZV), or Shingrix, if you have had an ocular shingles event, may increase your risk of experiencing a second event, a recent study shows. Ocular... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Alarming News for the Shingle Vaccine Recipients
Alarming News for the Shingle Vaccine Recipients
By Marina Zhang
Share* Read More
Epoch Health
MOST SHARED
FDA Drops a Bombshell on the Vaccinated—After 3 Years
FDA Drops a Bombshell on the Vaccinated—After 3 Years
By Marina Zhang
Share* Read More
image alt
Dear Reader,
We heard your voice!

There are many forces in our society today that don't want the truth to be told.

That's why The Epoch Times is not just another journalism—we're your ally in the fight for transparency and honesty.

Start the journey with us today and see the difference yourself. Our special trial subscription is just 25¢ per week for one year.

Act fast—time is running out for all the truth you deserve to know.
Get 25¢ A Week Now >
Offer ends soon. Cancel anytime!
Epoch Health
MOST DISCUSSED
Eat Your Way Out of Cancer: Sayer Ji | Live Webinar
Eat Your Way Out of Cancer: Sayer Ji | Live Webinar
By Dan Skorbach
Share* Read More
Epoch Health
MOST READ
CDC Data: Norovirus Cases on the Rise in the US, Namely the Northeast
CDC Data: Norovirus Cases on the Rise in the US, Namely the Northeast
By Jack Phillips
Share* Read More
Epoch Health
NEW RELEASE
Excess TV Linked to More Nighttime Bathroom Trips
Excess TV Linked to More Nighttime Bathroom Trips
By Amie Dahnke
Share* Read More
Epoch Times iOS     Epoch Times Android
mt

Aucun commentaire:

Enregistrer un commentaire